Early Capsule Endoscopy in Acute Upper Gastrointestinal Bleeding.

Not Applicable

Recruiting

• Conditions: Acute upper gastrointestinal bleeding; Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon

• Registration Number: ACTRN12616000636459
• Lead Sponsor: QLD Health

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-05-17
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Participants will be males or females who present with acute melaena and/or haematemesis and have a negative gastroscopy.

Exclusion Criteria

Patients less than 18 years of age and pregnant females will be excluded form this study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary outcome will be the proportion of patients in whom a source of bleeding is identified on capsule endoscopy or colonoscopy.[The primary timepoint will be 1 day after the colonoscopy or capsule endoscopy.]

Secondary Outcome Measures

Name	Time	Method
A secondary outcome will be number of blood transfusions received by a patient which will be determined through review of their electronic medical records.[3 months after initial presentation];A secondary outcome will be length of hospital stay which will be determined through review of electronic medical records.[3 months after initial presentation];A secndary outcome will be number of hospital representations which will be determined through review of the electronic medical records.[3 months after initial presentation]